Creating Eugène Marquis Cancer Centre Trials

From Beacon

Warning: You are recreating a page that was previously deleted.

You should consider whether it is appropriate to continue editing this page. The deletion and move log for this page are provided here for convenience:

  • 01:49, 23 June 2024 Victor talk contribs deleted page Eugène Marquis Cancer Centre Trials (content was: "'''NCTID''': NCT02444000 '''Title''': gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas '''Study Summary''': Patients with 1p/19q-codeleted anaplastic gliomas treated with RT + PCV are at risk of neurocognitive deterioration. Treating these patients with PCV alone (could reduce the risk of neurocognitive deterioration without impairing overall survival. '''Sponsor''...", and the only contributor was "Woloski" (talk))
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Please note that all contributions to Beacon may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see Beacon:Copyrights for details). Do not submit copyrighted work without permission!
Cancel Editing help (opens in new window)